We are analyzing https://link.springer.com/article/10.1007/s10555-021-09988-w.

Title:
The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions | Cancer and Metastasis Reviews
Description:
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies and is characterized by a unique tumor microenvironment (TME) consisting of an abundant stromal component. Many features contained with the PDAC stroma contribute to resistance to cytotoxic and immunotherapeutic regimens, as well as the propensity for this tumor to metastasize. At the cellular level, PDAC cells crosstalk with a complex mixture of non-neoplastic cell types including fibroblasts, endothelial cells, and immune cells. These intricate interactions fuel the progression and therapeutic resistance of this aggressive cancer. Moreover, data suggest the polarization of these cell types, in particular immune and fibroblast populations, dictate how PDAC tumors grow, metastasize, and respond to therapy. As a result, current research is focused on how to best target these populations to render tumors responsive to treatment. Herein, we summarize the cell populations implicated in providing a supporting role for the development and progression of PDAC. We focus on stromal fibroblasts and immune subsets that have been widely researched. We discuss factors which govern the phenotype of these populations and provide insight on how they have been targeted therapeutically. This review provides an overview of the tumor microenvironment and postulates that cellular and soluble factors within the microenvironment can be specifically targeted to improve patient outcomes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

pubmed, pancreatic, cancer, article, google, scholar, cas, central, adenocarcinoma, cells, ductal, cell, journal, tumor, research, microenvironment, nature, immunology, immune, clinical, fibroblasts, stromal, immunotherapy, human, pdac, promote, macrophages, patients, development, pancreas, cancerassociated, signaling, oncology, immunity, metastasis, lesinski, progression, discovery, myeloid, myeloidderived, suppressor, therapy, tumour, gastroenterology, metastatic, stellate, gut, targeting, science, promotes,

Topics {✒️}

nab-paclitaxel/gemcitabine versus nab-paclitaxel/gemcitabine cross-species single-cell analysis month download article/chapter c-met-targeting antibody-drug conjugate anti-alpha-enolase antibody limits cell-dependent antitumor immunity tumour cell-derived debris single-center retrospective analysis myeloid-derived suppressor cells tumor-induced stat3 activation pd-1/pd-l1 checkpoint activation lymphocyte-mediated immune suppression tumor-stromal interactions contributes blocking cxcls-cxcr2 axis nab-paclitaxel/gemcitabine enabling anti-tumor immunity ink4a/arf deficiency cooperate beta-catenin expression correlate fibroblasts promote angiogenesis immune-inflammatory microenvironment pancreatic tumor microenvironment febs open bio kras-induced pancreatic tumorigenesis unique tumor microenvironment vitamin a-storing cell il-1beta recruit stroma-rich xenograft model full article pdf collagen i-mediated reduced cell invasion/migration stromal microenvironment shapes pancreatic tumour cells orthotopic murine models tumor-infiltrating cd8 anti-pd-l1 immunotherapy il-6 signaling blockade cell mediated immunity analogue calcipotriol promotes jak-stat3 signaling promote tumor progression regulatory il-10 phenotype tumor cell proliferation tumour-host interface pancreatic neoplastic transformation privacy choices/manage cookies n-cadherin expression pancreatic ductal adenocarcinoma advanced pancreatic adenocarcinoma anti-inflammatory properties prognostic factors related

Questions {❓}

Pancreatic ductal adenocarcinoma epidemiology and risk assessment: Could we prevent?
Acinar?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
         description:Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies and is characterized by a unique tumor microenvironment (TME) consisting of an abundant stromal component. Many features contained with the PDAC stroma contribute to resistance to cytotoxic and immunotherapeutic regimens, as well as the propensity for this tumor to metastasize. At the cellular level, PDAC cells crosstalk with a complex mixture of non-neoplastic cell types including fibroblasts, endothelial cells, and immune cells. These intricate interactions fuel the progression and therapeutic resistance of this aggressive cancer. Moreover, data suggest the polarization of these cell types, in particular immune and fibroblast populations, dictate how PDAC tumors grow, metastasize, and respond to therapy. As a result, current research is focused on how to best target these populations to render tumors responsive to treatment. Herein, we summarize the cell populations implicated in providing a supporting role for the development and progression of PDAC. We focus on stromal fibroblasts and immune subsets that have been widely researched. We discuss factors which govern the phenotype of these populations and provide insight on how they have been targeted therapeutically. This review provides an overview of the tumor microenvironment and postulates that cellular and soluble factors within the microenvironment can be specifically targeted to improve patient outcomes.
         datePublished:2021-09-30T00:00:00Z
         dateModified:2021-09-30T00:00:00Z
         pageStart:675
         pageEnd:689
         sameAs:https://doi.org/10.1007/s10555-021-09988-w
         keywords:
            Pancreatic cancer
            Cancer-associated fibroblasts
            Tumor microenvironment immunotherapy
            Cancer Research
            Oncology
            Biomedicine
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-021-09988-w/MediaObjects/10555_2021_9988_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-021-09988-w/MediaObjects/10555_2021_9988_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-021-09988-w/MediaObjects/10555_2021_9988_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-021-09988-w/MediaObjects/10555_2021_9988_Fig4_HTML.png
         isPartOf:
            name:Cancer and Metastasis Reviews
            issn:
               1573-7233
               0167-7659
            volumeNumber:40
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Cameron J. Herting
               affiliation:
                     name:Winship Cancer Institute of Emory University
                     address:
                        name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Isaac Karpovsky
               affiliation:
                     name:Winship Cancer Institute of Emory University
                     address:
                        name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gregory B. Lesinski
               affiliation:
                     name:Winship Cancer Institute of Emory University
                     address:
                        name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
      description:Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies and is characterized by a unique tumor microenvironment (TME) consisting of an abundant stromal component. Many features contained with the PDAC stroma contribute to resistance to cytotoxic and immunotherapeutic regimens, as well as the propensity for this tumor to metastasize. At the cellular level, PDAC cells crosstalk with a complex mixture of non-neoplastic cell types including fibroblasts, endothelial cells, and immune cells. These intricate interactions fuel the progression and therapeutic resistance of this aggressive cancer. Moreover, data suggest the polarization of these cell types, in particular immune and fibroblast populations, dictate how PDAC tumors grow, metastasize, and respond to therapy. As a result, current research is focused on how to best target these populations to render tumors responsive to treatment. Herein, we summarize the cell populations implicated in providing a supporting role for the development and progression of PDAC. We focus on stromal fibroblasts and immune subsets that have been widely researched. We discuss factors which govern the phenotype of these populations and provide insight on how they have been targeted therapeutically. This review provides an overview of the tumor microenvironment and postulates that cellular and soluble factors within the microenvironment can be specifically targeted to improve patient outcomes.
      datePublished:2021-09-30T00:00:00Z
      dateModified:2021-09-30T00:00:00Z
      pageStart:675
      pageEnd:689
      sameAs:https://doi.org/10.1007/s10555-021-09988-w
      keywords:
         Pancreatic cancer
         Cancer-associated fibroblasts
         Tumor microenvironment immunotherapy
         Cancer Research
         Oncology
         Biomedicine
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-021-09988-w/MediaObjects/10555_2021_9988_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-021-09988-w/MediaObjects/10555_2021_9988_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-021-09988-w/MediaObjects/10555_2021_9988_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-021-09988-w/MediaObjects/10555_2021_9988_Fig4_HTML.png
      isPartOf:
         name:Cancer and Metastasis Reviews
         issn:
            1573-7233
            0167-7659
         volumeNumber:40
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Cameron J. Herting
            affiliation:
                  name:Winship Cancer Institute of Emory University
                  address:
                     name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Isaac Karpovsky
            affiliation:
                  name:Winship Cancer Institute of Emory University
                  address:
                     name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gregory B. Lesinski
            affiliation:
                  name:Winship Cancer Institute of Emory University
                  address:
                     name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer and Metastasis Reviews
      issn:
         1573-7233
         0167-7659
      volumeNumber:40
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Winship Cancer Institute of Emory University
      address:
         name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
         type:PostalAddress
      name:Winship Cancer Institute of Emory University
      address:
         name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
         type:PostalAddress
      name:Winship Cancer Institute of Emory University
      address:
         name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Cameron J. Herting
      affiliation:
            name:Winship Cancer Institute of Emory University
            address:
               name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Isaac Karpovsky
      affiliation:
            name:Winship Cancer Institute of Emory University
            address:
               name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Gregory B. Lesinski
      affiliation:
            name:Winship Cancer Institute of Emory University
            address:
               name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
      name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
      name:Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(485)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.27s.

LINK . SPRINGER . COM {}